ASIPP Practice Guidelines - Pain Physician

Manchikanti et al • ASIPP Practice Guidelines
97
769. Mikhail Gr, Livingood Cs, Mellinger RC et al. Effect
of long-acting parenteral corticosteroids on adrenal
function. Arch Dermatol 1969; 100:263-268.
770. Melby JC. Drug spotlight program: Systemic corticosteroid
therapy; pharmacologic and endocrinologic
considerations. Ann Intern Med 1974; 81:505-512.
771. Schimmer BP, Parker KL. Adrenocorticotropic hormone;
adrenocortical steroids and their synthetic analogs;
inhibitors of the synthesis and actions of adrenocortical
hormones. In Harman JG, Molinoff PB,
Ruddon RW (eds). Goodman’s & Gilman’s , The Pharmacological
Basis of Therapeutics, Ninth Edition,
McGraw-Hill, New York, 1996, pp 1459-1485.
772. McEvoy GK, Litvak K, Welsh OH et al. Adrenals.
AHFS 99 drug information. American Society of
Health-System Pharmacists, Bethesda, 1999, pp 2636-
2662.
773. Boonen S, Van Distel G, Westhovens R et al. Steroid
myopathy induced by epidural triamcinolone injection.
Brit J Rheumatol 1995; 34:385.
774. Sandberg DI, Lavyne MH. Symptomatic spinal epidural
lipomatosis after local epidural corticosteroid
injections: Case report. Neurosurgery 1999; 45:162-
165.
775. Manchikanti L, Pampati VS, Beyer C et al. The effect
of neuraxial steroids on weight and bone mass density:
A prospective evaluation. Pain Physician 2000;
3:357-366.
776. Aldrete JA, Zapata JC, Ghaly R. Arachnoiditis following
epidural adhesiolysis with hypertonic saline
report of two cases. Pain Digest 1996; 6:368-370.
777. Heavner JE. Comments on arachnoiditis following
epidural adhesiolysis. Pain Digest 1997; 7:157.
778. Manchikanti L. Comments on arachnoiditis following
epidural adhesiolysis. Pain Digest 1997; 7:157-
158.
779. Erdine S, Ozyalcin S. Comments on arachnoiditis following
epidural adhesiolysis. Pain Digest 1997; 7:158-
159.
780. Kim RC, Porter RW, Choi BH et al. Myelopathy after
intrathecal administration of hypertonic saline. Neurosurgery
1988; 22:942-944.
781. Lucas JS, Ducker TB, Perot PL. Adverse reactions to
intrathecal saline injections for control of pain. J
Neurosurg 1975; 42:57-561.
782. Hitchcock ER, Prandini MN. Hypertonic saline in
management of intractable pain. Lancet 1973; 1:310-
312.
783. Manchikanti L, Bakhit CE. Removal of torn Racz catheter
from lumbar epidural space. Reg Anesth 1997;
22:579-581.
784. Delaney TJ, Rowlingson JC, Carron H et al. Epidural
steroid effects on nerves and meninges. Anesth Analg
1980; 58:610-614.
785. Cicala RS, Turner R, Moran E et al. Methylprednisolone
acetate does not cause inflammatory changes in
the epidural space. Anesthesiology 1990; 72:556-558.
786. MacKinnon Se, Hudson AR, Gentilli R et al. Peripheral
nerve injection injury with steroid agents. Plast
Reconstr Surg 1982; 69:482-489.
787. Chino N, Awad EA, Kottke FJ. Pathology of propylene
glycol administered by perineural and intramuscular
injection in rats. Arch Phys Med Rehab 1974;
55:33-38.
788. Benzon HT, Gissen AJ, Strichartz GR et al. The effect
of polyethylene glycol on mammalian nerve impulses.
Anesth Analg 1987; 66:553-559.
789. Abram SE, Marsala M, Yaksh TL. Analgesic and neurotoxic
effects of intrathecal corticosteroids in rats.
Anesthesiology 1994; 81:1198-1205.
790. Latham JM, Fraser RD, Moore RJ et al. The pathologic
effects of intrathecal betamethasone. Spine 1997;
22:1558-1562.
791. Hammer M, Meneese W. Principles and practice of
radiofrequency neurolysis. Cur Rev Pain 1998; 2:267-
278.
792. Saberski LR, Ahmad M, Fitzgerald J et al. Practice
patterns in the use of epidural corticosteroid injections.
A survey of the Connecticut State Society of Anesthesiologists.
(Poster Exhibits). Anesthesiology 1998;
101.
793. Hopwood M. Outcomes assessment in pain management.
In Abram SE (ed). Pain Management.
Churchill-Livingston, Philadelphia, 1998, pp 14.1-
14.11.
794. Piccirillo JF. Outcomes research and otolaryngology.
Otolaryngol Head Neck Surg 1994; 111:764-769.
795. Ross Davies A, Doyle AT, Lansky D et al. Outcomes
assessment in clinical settings: A consensus statement
on principles and best practices in project management.
Jt Comm J Qual Improvement 1994; 20(1):6-16.
796. The Foundation for Health Services Research. Health
Outcomes Research Primer. The Foundation for Health
Services Research, Washington, 1994.
797. Epstein RS, Sherwood LM. From outcomes research
to disease management: A guide for the perplexed. Ann
Intern Med 1996; 124:832-837.
798. Greenfield S, Kaplan SH, Silliman RA et al. The uses
of outcomes research for medical effectiveness, quality
of care, and reimbursement in Type II diabetes.
Diabetes Care 1994; 17:32-39.
799. Lynn J, Virnig BA. Assessing the significance of treatment
effects: Comments from the perspective of ethics.
Med Care 1995; 33:AS292-AS298.
800. Wilson IB, Kaplan S. Clinical practice and patient
health status: How are the two related? Med Care
1995; 33:AS209-AS214.
801. Fowler FJ. Using patient reports to evaluate medical
outcomes. United States Congress, Office of Technology
Assessment. Tools for Evaluating Health Technologies.
Background Paper Five, BP-H-142. U.S.
Government Printing Office, Washington, February,
1995.
802. Cicala RS, Wright H. Outpatient treatment of patients
Pain Physician Vol. 4, No. 1, 2001